Skip to main content
Log in

Trends in cardiac implantable electronic device utilization in adults with congenital heart disease: a US nationwide analysis

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Background

Adults with congenital heart disease (ACHD) have increased risk of arrhythmias warranting implantation of cardiac implantable electronic devices (CIEDs), which may parallel the observed increase in survival of ACHD patients over the past few decades. We sought to characterize the trends and outcomes of CIED implantation in the inpatient ACHD population across US from 2005 to 2019.

Methods

A retrospective analysis of the Nationwide Inpatient Sample (NIS) identified 1,599,519 unique inpatient ACHD admissions (stratified as simple (85.1%), moderate (11.5%), and complex (3.4%)) using the International Classification of Diseases 9/10-CM codes. Hospitalizations for CIED implantation (pacemaker, ICD, CRT-p/CRT-d) were identified and the trends analyzed using regression analysis (2-tailed p < 0.05 was considered significant).

Results

A significant decrease in the hospitalizations for CIED implantation across the study period [3.3 (2.9–3.8)% in 2005 vs 2.4 (2.1–2.6)% in 2019, p < 0.001] was observed across all types of devices and CHD severities. Pacemaker implantation increased with each age decade, whereas ICD implantation rates decreased over 70 years of age. Complex ACHD patients receiving CIED were younger with a lower prevalence of age-related comorbidities, however, had a greater prevalence of atrial/ventricular tachyarrhythmias and complete heart block. The observed inpatient mortality rate was 1.2%.

Conclusions

In a nationwide analysis, we report a significant decline in CIED implantation between 2005 and 2019 in ACHD patients. This may either be due to a greater proportion of hospitalizations resulting from other complications of ACHD or reflect a declining need for CIED due to advances in medical/surgical therapies. Future prospective studies are needed to elucidate this trend further.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014;130:749–56.

    Article  PubMed  Google Scholar 

  2. Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e698–800.

    PubMed  Google Scholar 

  3. Khairy P, Van Hare GF, Balaji S, et al. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm. 2014;11:e102-65.

    Article  PubMed  Google Scholar 

  4. Opotowsky AR, Siddiqi OK, Webb GD. Trends in hospitalizations for adults with congenital heart disease in the U.S. J Am Coll Cardiol. 2009;54:460–7.

    Article  PubMed  Google Scholar 

  5. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4:e296.

    Article  Google Scholar 

  6. Kurtz SM, Ochoa JA, Lau E, et al. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993–2006. Pacing Clin Electrophysiol. 2010;33:705–11.

    Article  PubMed  Google Scholar 

  7. Haddadin F, Majmundar M, Walker A, et al. Temporal trends in cardiovascular implantable electronic device implants and upgrades in US between 2016–2019: insights from the national inpatient database. J Am Coll Cardiol. 2023;81(8_Supplement):116.

    Google Scholar 

  8. Burstein DS, Rossano JW, Griffis H, et al. Greater admissions, mortality and cost of heart failure in adults with congenital heart disease. Heart. 2021;107:807–13.

    Article  CAS  PubMed  Google Scholar 

  9. Bassareo PP, Walsh KP. Micra pacemaker in adult congenital heart disease patients: a case series. J Cardiovasc Electrophysiol. 2022;33:2335–43.

    Article  PubMed  Google Scholar 

  10. Silka MJ, Hardy BG, Menashe VD, Morris CD. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol. 1998;32:245–51.

    Article  CAS  PubMed  Google Scholar 

  11. Vehmeijer JT, Brouwer TF, Limpens J, et al. Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis. Eur Heart J. 2016;37:1439–48.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Kaiser DW, Tsai V, Heidenreich PA, et al. Defibrillator implantations for primary prevention in the United States: inappropriate care or inadequate documentation: insights from the National Cardiovascular Data ICD Registry. Heart Rhythm. 2015;12:2086–93.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Rodriguez FH 3rd, Moodie DS, Parekh DR, et al. Outcomes of heart failure-related hospitalization in adults with congenital heart disease in the United States. Congenit Heart Dis. 2013;8:513–9.

    Article  PubMed  Google Scholar 

  14. Nothroff J, Norozi K, Alpers V, et al. Pacemaker implantation as a risk factor for heart failure in young adults with congenital heart disease. Pacing Clin Electrophysiol. 2006;29:386–92.

    Article  PubMed  Google Scholar 

  15. Janousek J, Gebauer RA, Abdul-Khaliq H, et al. Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates. Heart. 2009;95:1165–71.

    Article  CAS  PubMed  Google Scholar 

  16. Loomba RS, Buelow MW, Aggarwal S, Arora RR, Kovach J, Ginde S. Arrhythmias in adults with congenital heart disease: what are risk factors for specific arrhythmias? Pacing Clin Electrophysiol. 2017;40:353–61.

    Article  PubMed  Google Scholar 

  17. Chatterjee NA, Borgquist R, Chang Y, et al. Increasing sex differences in the use of cardiac resynchronization therapy with or without implantable cardioverter-defibrillator. Eur Heart J. 2017;38:1485–94.

    PubMed  PubMed Central  Google Scholar 

  18. Patel NJ, Edla S, Deshmukh A, et al. Gender, racial, and health insurance differences in the trend of implantable cardioverter-defibrillator (ICD) utilization: a United States experience over the last decade. Clin Cardiol. 2016;39:63–71.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA. 2007;298:1517–24.

    Article  CAS  PubMed  Google Scholar 

  20. Baskar S, Veldtman GR, Khoury PR, Opotowsky AR, Cedars AM. Characteristics of hospital admissions associated with implantable cardioverter defibrillator placement among adults with congenital heart disease. Int J Cardiol. 2018;269:97–103.

    Article  PubMed  Google Scholar 

  21. Maxwell BG, Steppan J, Cheng A. Complications of catheter-based electrophysiology procedures in adults with congenital heart disease: a national analysis. J Cardiothorac Vasc Anesth. 2015;29:258–64.

    Article  PubMed  Google Scholar 

  22. Opic P, van Kranenburg M, Yap SC, et al. Complications of pacemaker therapy in adults with congenital heart disease: a multicenter study. Int J Cardiol. 2013;168:3212–6.

    Article  PubMed  Google Scholar 

  23. McLeod CJ, AttenhoferJost CH, Warnes CA, et al. Epicardial versus endocardial permanent pacing in adults with congenital heart disease. J Interv Card Electrophysiol. 2010;28:235–43.

    Article  PubMed  Google Scholar 

  24. Kichloo A, Shaka H, Aljadah M, et al. Predictors of outcomes in hospitalized patients undergoing pacemaker insertion: analysis from the national inpatient database (2016–2017). Pacing Clin Electrophysiol. 2021;44:1562–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Jaideep S. Bhalla: investigation, data curation, writing: original draft preparation; Monil Majmundar: conceptualization, methodology, formal analysis; Abhishek J. Deshmukh: validation, supervision; Heidi M. Connolly: writing: review and editing; Anca Chirac: data curation, writing: review and editing; Alexander C. Egbe: writing: review and editing; William R. Miranda: writing: review and editing, supervision; Malini Madhavan: conceptualization, validation, writing: review and editing.

Corresponding author

Correspondence to Jaideep Singh Bhalla.

Ethics declarations

Ethical approval

Not applicable.

Informed consent

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 41 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhalla, J.S., Majmundar, M., Patel, K.N. et al. Trends in cardiac implantable electronic device utilization in adults with congenital heart disease: a US nationwide analysis. J Interv Card Electrophysiol 67, 319–328 (2024). https://doi.org/10.1007/s10840-023-01601-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-023-01601-0

Keywords

Navigation